Here, we demonstrate detection by mass spectrometry of an intact protein-drug complex directly from liver tissue from rats that had been orally dosed with the drug. The protein-drug complex comprised fatty acid binding protein 1, FABP1, non-covalently bound to the small molecule therapeutic bezafibrate. Moreover, we demonstrate spatial mapping of the [FABP1+bezafibrate] complex across a thin section of liver by targeted mass spectrometry imaging. This work is the first demonstration of mass spectrometry analysis of a non-covalent protein-drug complex formed and has implications for early stage drug discovery by providing a route to target-drug characterization directly from the physiological environment.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10946869 | PMC |
http://dx.doi.org/10.1002/ange.202202075 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!